Growth factor: Difference between revisions
imported>Gadfium rv test |
imported>Monkbot |
||
| Line 4: | Line 4: | ||
{{Use dmy dates|date=July 2020}} | {{Use dmy dates|date=July 2020}} | ||
A '''growth factor''' is a naturally occurring substance capable of stimulating [[cell proliferation]], [[wound healing]], and occasionally [[cellular differentiation]].<ref>{{DorlandsDict|three/000038554|growth factor}}</ref> Usually it is a secreted [[protein]] or a [[steroid hormone]] | A '''growth factor''' is a naturally occurring substance capable of stimulating [[cell proliferation]], [[wound healing]], and occasionally [[cellular differentiation]].<ref>{{DorlandsDict|three/000038554|growth factor}}</ref> Usually it is a secreted [[protein]] or a [[steroid hormone]]. | ||
{{anchor|cytokine}} | {{anchor|cytokine}} | ||
| Line 16: | Line 12: | ||
While ''growth factor'' implies a positive effect on [[cell proliferation]], ''cytokine'' is a neutral term with respect to whether a molecule affects proliferation. While some cytokines can be growth factors, such as [[Granulocyte colony-stimulating factor|G-CSF]] and [[Granulocyte macrophage colony-stimulating factor|GM-CSF]], others have an inhibitory effect on [[cell growth]] or cell proliferation. Some cytokines, such as [[Fas ligand]], are used as "death" signals; they cause target cells to undergo programmed [[cell death]] or ''[[apoptosis]]''. | While ''growth factor'' implies a positive effect on [[cell proliferation]], ''cytokine'' is a neutral term with respect to whether a molecule affects proliferation. While some cytokines can be growth factors, such as [[Granulocyte colony-stimulating factor|G-CSF]] and [[Granulocyte macrophage colony-stimulating factor|GM-CSF]], others have an inhibitory effect on [[cell growth]] or cell proliferation. Some cytokines, such as [[Fas ligand]], are used as "death" signals; they cause target cells to undergo programmed [[cell death]] or ''[[apoptosis]]''. | ||
== List of classes == | == List of classes == | ||
{{Incomplete list|date=February 2011}} | {{Incomplete list|date=February 2011}} | ||
{{no references|section|date=August 2025}} | |||
Individual growth factor proteins tend to occur as members of larger families of structurally and [[evolution]]arily related proteins. There are many families, some of which are listed below: | Individual growth factor proteins tend to occur as members of larger families of structurally and [[evolution]]arily related proteins. There are many families, some of which are listed below: | ||
* [[Adrenomedullin]] (AM) | * [[Adrenomedullin]] (AM) | ||
| Line 27: | Line 22: | ||
* [[Bone morphogenetic protein]]s (BMPs) | * [[Bone morphogenetic protein]]s (BMPs) | ||
* Ciliary neurotrophic factor family | * Ciliary neurotrophic factor family | ||
* [[Colony-stimulating factor]]s | * [[Colony-stimulating factor]]s | ||
* [[Epidermal growth factor]] (EGF) | * [[Epidermal growth factor]] (EGF) | ||
* [[Ephrin]]s | * [[Ephrin]]s | ||
* [[Erythropoietin]] (EPO) | * [[Erythropoietin]] (EPO) | ||
* [[Fibroblast growth factor]] (FGF) | * [[Fibroblast growth factor]] (FGF) | ||
* [[Bovine somatotropin|Foetal Bovine Somatotrophin]] (FBS) | * [[Bovine somatotropin|Foetal Bovine Somatotrophin]] (FBS) | ||
* [[GDNF family of ligands]] | * [[GDNF family of ligands]] | ||
* [[Growth differentiation factor-9]] (GDF9) | * [[Growth differentiation factor-9]] (GDF9) | ||
* [[Hepatocyte growth factor]] (HGF) | * [[Hepatocyte growth factor]] (HGF) | ||
| Line 80: | Line 34: | ||
* [[Insulin]] | * [[Insulin]] | ||
* [[Insulin-like growth factor]]s | * [[Insulin-like growth factor]]s | ||
*Interleukins | *Interleukins | ||
* [[Keratinocyte growth factor]] (KGF) | * [[Keratinocyte growth factor]] (KGF) | ||
* [[PRG4|Migration-stimulating factor]] (MSF) | * [[PRG4|Migration-stimulating factor]] (MSF) | ||
| Line 95: | Line 40: | ||
* [[Myostatin]] (GDF-8) | * [[Myostatin]] (GDF-8) | ||
* [[Neuregulin]]s | * [[Neuregulin]]s | ||
* [[Neurotrophins]] | * [[Neurotrophins]] | ||
* [[Placental growth factor]] (PGF) | * [[Placental growth factor]] (PGF) | ||
* [[Platelet-derived growth factor]] (PDGF) | * [[Platelet-derived growth factor]] (PDGF) | ||
| Line 110: | Line 47: | ||
* [[Thrombopoietin]] (TPO) | * [[Thrombopoietin]] (TPO) | ||
* [[Transforming growth factor]]s | * [[Transforming growth factor]]s | ||
* [[Tumor necrosis factor-alpha]] (TNF-α) | * [[Tumor necrosis factor-alpha]] (TNF-α) | ||
* [[Vascular endothelial growth factor]] (VEGF) | * [[Vascular endothelial growth factor]] (VEGF) | ||
| Line 119: | Line 54: | ||
== Uses in medicine == | == Uses in medicine == | ||
For the last two decades, growth factors have been increasingly used in the treatment of [[hematology|hematologic]] and [[oncology|oncologic]] diseases<ref>{{cite journal | vauthors = Cottler-Fox M, Klein HG | title = Transfusion support of hematology and oncology patients. The role of recombinant hematopoietic growth factors | journal = Archives of Pathology & Laboratory Medicine | volume = 118 | issue = 4 | pages = 417–20 | date = April 1994 | pmid = 7909429 }}</ref><ref>{{cite journal | vauthors = Aaronson SA | title = Growth factors and cancer | journal = Science | volume = 254 | issue = 5035 | pages = 1146–53 | date = November 1991 | pmid = 1659742 | doi = 10.1126/science.1659742 | bibcode = 1991Sci...254.1146A }}</ref> and cardiovascular diseases<ref>{{cite journal | vauthors = Domouzoglou EM, Naka KK, Vlahos AP, Papafaklis MI, Michalis LK, Tsatsoulis A, Maratos-Flier E | title = Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21 | journal = American Journal of Physiology. Heart and Circulatory Physiology | volume = 309 | issue = 6 | pages = H1029-38 | date = September 2015 | pmid = 26232236 | pmc = 4747916 | doi = 10.1152/ajpheart.00527.2015 }}</ref><ref>{{Cite journal|last1=Gorenoi|first1=Vitali|last2=Brehm|first2=Michael U.|last3=Koch|first3=Armin|last4=Hagen|first4=Anja|date=2017|title=Growth factors for angiogenesis in peripheral arterial disease|journal=The Cochrane Database of Systematic Reviews|volume=2017|issue=6 | | For the last two decades, growth factors have been increasingly used in the treatment of [[hematology|hematologic]] and [[oncology|oncologic]] diseases<ref>{{cite journal | vauthors = Cottler-Fox M, Klein HG | title = Transfusion support of hematology and oncology patients. The role of recombinant hematopoietic growth factors | journal = Archives of Pathology & Laboratory Medicine | volume = 118 | issue = 4 | pages = 417–20 | date = April 1994 | pmid = 7909429 }}</ref><ref>{{cite journal | vauthors = Aaronson SA | title = Growth factors and cancer | journal = Science | volume = 254 | issue = 5035 | pages = 1146–53 | date = November 1991 | pmid = 1659742 | doi = 10.1126/science.1659742 | bibcode = 1991Sci...254.1146A }}</ref> and cardiovascular diseases<ref>{{cite journal | vauthors = Domouzoglou EM, Naka KK, Vlahos AP, Papafaklis MI, Michalis LK, Tsatsoulis A, Maratos-Flier E | title = Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21 | journal = American Journal of Physiology. Heart and Circulatory Physiology | volume = 309 | issue = 6 | pages = H1029-38 | date = September 2015 | pmid = 26232236 | pmc = 4747916 | doi = 10.1152/ajpheart.00527.2015 }}</ref><ref>{{Cite journal|last1=Gorenoi|first1=Vitali|last2=Brehm|first2=Michael U.|last3=Koch|first3=Armin|last4=Hagen|first4=Anja|date=2017|title=Growth factors for angiogenesis in peripheral arterial disease|journal=The Cochrane Database of Systematic Reviews|volume=2017|issue=6 |article-number=CD011741|doi=10.1002/14651858.CD011741.pub2|issn=1469-493X|pmid=28594443|pmc=6481523}}</ref> such as: | ||
* [[skin wound healing and regeneration of other tissues such as bone]] (PDGF-BB) | * [[skin wound healing and regeneration of other tissues such as bone]] (PDGF-BB) | ||
Latest revision as of 20:27, 29 September 2025
Template:Short description Script error: No such module "redirect hatnote". Template:More citations needed Template:Use dmy dates
A growth factor is a naturally occurring substance capable of stimulating cell proliferation, wound healing, and occasionally cellular differentiation.[1] Usually it is a secreted protein or a steroid hormone.
Script error: No such module "anchor".
Comparison to cytokines
Growth factor is sometimes used interchangeably among scientists with the term cytokine.[2] Historically, cytokines were associated with hematopoietic (blood and lymph forming) cells and immune system cells (e.g., lymphocytes and tissue cells from spleen, thymus, and lymph nodes). For the circulatory system and bone marrow in which cells can occur in a liquid suspension and not bound up in solid tissue, it makes sense for them to communicate by soluble, circulating protein molecules. However, as different lines of research converged, it became clear that some of the same signaling proteins which the hematopoietic and immune systems use were also being used by all sorts of other cells and tissues, during development and in the mature organism.
While growth factor implies a positive effect on cell proliferation, cytokine is a neutral term with respect to whether a molecule affects proliferation. While some cytokines can be growth factors, such as G-CSF and GM-CSF, others have an inhibitory effect on cell growth or cell proliferation. Some cytokines, such as Fas ligand, are used as "death" signals; they cause target cells to undergo programmed cell death or apoptosis.
List of classes
Script error: No such module "Unsubst". Template:No references Individual growth factor proteins tend to occur as members of larger families of structurally and evolutionarily related proteins. There are many families, some of which are listed below:
- Adrenomedullin (AM)
- Angiopoietin (Ang)
- Autocrine motility factor
- Bone morphogenetic proteins (BMPs)
- Ciliary neurotrophic factor family
- Colony-stimulating factors
- Epidermal growth factor (EGF)
- Ephrins
- Erythropoietin (EPO)
- Fibroblast growth factor (FGF)
- Foetal Bovine Somatotrophin (FBS)
- GDNF family of ligands
- Growth differentiation factor-9 (GDF9)
- Hepatocyte growth factor (HGF)
- Hepatoma-derived growth factor (HDGF)
- Insulin
- Insulin-like growth factors
- Interleukins
- Keratinocyte growth factor (KGF)
- Migration-stimulating factor (MSF)
- Macrophage-stimulating protein (MSP), also known as hepatocyte growth factor-like protein (HGFLP)
- Myostatin (GDF-8)
- Neuregulins
- Neurotrophins
- Placental growth factor (PGF)
- Platelet-derived growth factor (PDGF)
- Renalase (RNLS) – Anti-apoptotic survival factor
- T-cell growth factor (TCGF)
- Thrombopoietin (TPO)
- Transforming growth factors
- Tumor necrosis factor-alpha (TNF-α)
- Vascular endothelial growth factor (VEGF)
In platelets
The alpha granules in blood platelets contain growth factors PDGF, IGF-1, EGF, and TGF-β which begin healing of wounds by attracting and activating macrophages, fibroblasts, and endothelial cells.
Uses in medicine
For the last two decades, growth factors have been increasingly used in the treatment of hematologic and oncologic diseases[3][4] and cardiovascular diseases[5][6] such as:
- skin wound healing and regeneration of other tissues such as bone (PDGF-BB)
- neutropenia
- myelodysplastic syndrome (MDS)
- leukemias
- aplastic anaemia
- bone marrow transplantation
- angiogenesis for cardiovascular diseases
See also
- Angiogenesis
- Bone growth factor
- Cytokine
- Growth factor receptor
- Human Genome Organisation
- Mitogen
- Neurotrophic factor
- Receptor (biochemistry)
- Signal transduction
- Template:Slink
References
External links
Template:Signaling proteins Template:Cytokines Template:Wound healing Template:Growth factor receptor modulators